Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
LR

Laszlo Radvanyi — 11 Patents

SPSanofi Pasteur: 7 patents #16 of 238Top 7%
IBIovance Biotherapeutics: 2 patents #14 of 21Top 70%
University Of Texas System: 1 patents #2,951 of 6,559Top 45%
Houston, TX: #2,053 of 21,073 inventorsTop 10%
Texas: #13,915 of 125,132 inventorsTop 15%
Overall (All Time): #435,149 of 4,157,543Top 15%
11 Patents All Time
Laszlo Radvanyi has been granted 11 US patents while listed as an inventor at Sanofi Pasteur. The first was granted in 2010 and the most recent in July 2024. Laszlo Radvanyi ranks #435,149 of 4,157,543 US inventors in our database (top 10.5%). Patent records list Laszlo Radvanyi in Houston, TX, US.

Issued Patents All Time

Showing 1–11 of 11 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
12023355 Programmed death 1 ligand 1 (PD-L1) binding proteins and methods of use thereof Brian Rabinovich, Natalia Martin-Orozco 2024-07-02 $24,826,000
11401506 Enhanced expansion of tumor-infiltrating lymphocytes for adoptive cell therapy Amod A. Sarnaik, Jeffrey S. Weber, Shari Pilon-Thomas, Jessica Ann Chacon, James J. Mulé +1 more 2022-08-02
11141434 Programmed death 1 ligand 1 (PD-L1) binding proteins and methods of use thereof Brian Rabinovich, Natalia Martin-Orozco 2021-10-12 $33,146,000
9512401 B and T lymphocyte attenuator marker for use in adoptive T-cell therapy Patrick Hwu, Chantale BERNATCHEZ 2016-12-06
8946174 Tumor antigens BFA4 and BCY1 for prevention and / or treatment of cancer Neil Berinstein, Corey Lovitt, Mark Parrington, Artur Pedyczak, Scott Gallichan +3 more 2015-02-03 $34,253,000
8802383 Monoclonal antibodies and uses thereof Neil Berinstein, Devender Satsangi Singh Sandhu, Corey Lovitt, Artur Pedyczak, Scott Gallichan 2014-08-12 $12,973,000
8361706 Monoclonal antibodies and uses thereof Neil Berinstein, Devender Singh-Sandhu, Corey Lovitt, Artur Pedyczak, Scott Gallichan 2013-01-29 $11,134,000
8207314 Tumor antigens for prevention and/or treatment of cancer Neil Berinstein, Scott Gallichan, Corey Lovitt, Mark Parrington, Devender Singh-Sandhu 2012-06-26 $10,475,000
8021664 Tumor antigens Bfa5 for prevention and/or treatment of cancer Neil Berinstein, Scott Gallichan, Corey Lovitt, Mark Parrington, Artur Pedyczak +1 more 2011-09-20 $39,185,000
7851213 Tumor antigens BFA4 and BCY1 for prevention and / or treatment of cancer Neil Berinstein, Corey Lovitt, Mark Parrington, Artur Pedyczak, Scott Gallichan +3 more 2010-12-14 $5,381,000
7790857 Monoclonal antibodies and uses thereof Neil Berinstein, Devender Singh-Sandhu, Corey Lovitt, Artur Pedyczak 2010-09-07 $13,809,000